Weekly Roundup: January 1-5, 2024

Cyber risks to defense industrial supply chains are ‘substantially worse’ than other concerns. There is an outright conflict between cybersecurity and supply chain risk management (SCRM), and simply adding those together can lead to an increase in cyberattacks, a new report finds.

Workforce: Insights on Resiliency

Insights detailed in this chapter derive from the IBM Center blog, Preparing Government Workforces for Future Shocks as well as informed by the Future Shock roundtable discussion and resources.

Sustainability: Insights on Resiliency

Insights detailed in this chapter derive from the IBM Center report, Preparing Governments for Future Shocks: Building Climate Resilience, as well as informed by the Future Shock roundtable discussion and resources.

Special Edition of The Business of Government Hour – Insights on Leadership, Mindset, and Thriving on Disruption

How can the U.S. federal government rebuild its digital capabilities and truly transform how government does business? What is the difference between learning while doing and learning by doing? How can government agencies become more adaptive and thrive on disruption. Join host Michael Keegan as he explores these questions and more with thought leaders interviewed this year on The Business of Government Hour.
Broadcast Date: 
Monday, April 22, 2024 - 10:33

Leadership in Action: On Mission and Execution - Special Edition

How are supplies and innovation delivered effectively to the warfighters? What are the best ways to deliver products and services to federal agencies? How are federal agency’s Putting People First? Join host Michael Keegan as he explores these questions and more with a host of government leaders interviewed this year on The Business of Government Hour.
Broadcast Date: 
Monday, December 25, 2023 - 11:00

Aaron S. Kesselheim, M.D., J.D., M.P.H.

Aaron S. Kesselheim, M.D., J.D., M.P.H. is a Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital. He is a primary care physician at the Phyllis Jen Center for Primary Care at Brigham and Women’s Hospital. Within the Division, Aaron created and helps lead the Program On Regulation, Therapeutics, And Law (PORTAL, www.PORTALresearch.org), an interdisciplinary research center

C. Joseph Ross Daval, J.D.

C. Joseph Ross Daval, J.D. is a research fellow at the Program on Regulation, Therapeutics, and Law (PORTAL), at Brigham & Women’s Hospital and Harvard Medical School. His work has appeared in JAMA, the New England Journal of Medicine, and Health Affairs, and examines how prescription drug

Building Public Trust in Scientific Decision Making through Expert Advisory Committees

When faced with difficult decisions about new drugs or medical devices, the Food and Drug Administration (FDA) is authorized to consult with advisory committees of independent experts. Advisory committees provide critical scientific insights and credibility for FDA efficacy and safety determinations.

Weekly Roundup December 18-22, 2023

The amazing public servants the public doesn’t know. Tom Temin from federalnewsnetwork.com will be presenting a series of interviews with a sample of Rank awardees in the coming days. People doing good without cynicism or hope of riches — how’s that for the holiday season in a year when all the news seems bad?

Supply Chain: Insights on Resiliency

Insights detailed in this chapter derive from the IBM Center report, Preparing Governments for Future Shocks: Collaborating to Build Resilient Supply Chains, as well as informed by the Future Shock roundtable discussion and resources.

Pages